LC
AGIO icon

Lindbrook Capital’s Agios Pharmaceuticals AGIO Stock Holding History

Lindbrook Capital’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$7.53K Buy
257
+94
+58% +$3.12K ﹤0.01% 1777
2024
Q4 		$5.36K Hold
163
– – ﹤0.01% 1950
2024
Q3 		$7.24K Sell
163
-14
-8% -$636 ﹤0.01% 1839
2024
Q2 		$7.63K Buy
177
+30
+20% +$1.08K ﹤0.01% 1782
2024
Q1 		$4.3K Hold
147
– – ﹤0.01% 1958
2023
Q4 		$3.27K Sell
147
-10
-6% -$224 ﹤0.01% 2087
2023
Q3 		$3.89K Sell
157
-74
-32% -$1.96K ﹤0.01% 1876
2023
Q2 		$6.54K Buy
231
+136
+143% +$3.38K ﹤0.01% 1680
2023
Q1 		$2.18K Sell
95
-54
-36% -$1.43K ﹤0.01% 2206
2022
Q4 		$4.18K Buy
149
+37
+33% +$1.04K ﹤0.01% 1912
2022
Q3 		$3K Buy
112
+38
+51% +$1.02K ﹤0.01% 1829
2022
Q2 		$2K Buy
74
+63
+573% +$1.42K ﹤0.01% 1894
2022
Q1 		$0 Sell
11
-85
-89% -$2.6K ﹤0.01% 2462
2021
Q4 		$3K Sell
96
-39
-29% -$1.57K ﹤0.01% 1631
2021
Q3 		$6K Hold
135
– – ﹤0.01% 1162
2021
Q2 		$7K Hold
135
– – ﹤0.01% 1169
2021
Q1 		$7K Hold
135
– – ﹤0.01% 1133
2020
Q4 		$6K Sell
135
-52
-28% -$2.06K ﹤0.01% 1094
2020
Q3 		$7K Hold
187
– – ﹤0.01% 941
2020
Q2 		$10K Buy
187
+52
+39% +$2.41K ﹤0.01% 821
2020
Q1 		$5K Hold
135
– – ﹤0.01% 965
2019
Q4 		$6K Buy
+135
New +$5.1K ﹤0.01% 1044

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Lindbrook Capital's AGIO Position: Q1 2025 in Review

Lindbrook Capital increased its Agios Pharmaceuticals (AGIO) stake by 58% in Q1 2025, buying an estimated $3.12K and bringing the position to 257 shares worth $7.53K. The position accounts for ﹤0.01% of the portfolio, ranked #1777.

Lindbrook Capital first reported a position in AGIO in Q4 2019 and has held it in 22 quarters since. The position peaked at $10K in Q2 2020. 221 funds tracked by Wall St. Rank hold AGIO as of Q1 2025.

  • Lindbrook Capital held 257 shares of Agios Pharmaceuticals worth $7.53K as of Q1 2025.
  • Lindbrook Capital bought 94 Agios Pharmaceuticals shares in Q1 2025, an estimated $3.12K.
  • Agios Pharmaceuticals made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1777 holding.
  • Lindbrook Capital first reported a position in Agios Pharmaceuticals in Q4 2019 and has held it in 22 quarters since.
  • Lindbrook Capital's Agios Pharmaceuticals position peaked at $10K in Q2 2020.
  • 221 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.